Wells Fargo & Company »

Contineum Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Contineum Therapeutics shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-06-30 $45k 2.5k 17.61

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth Call Option (UNH)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Wells Fargo & Company

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Johnson & Johnson
Perceptive Advisors
Versant Venture Management
Hillhouse Capital Advisors
Franklin Resources
Samsara BioCapital
Vanguard Group
Altium Capital Management
BlackRock
Baker Bros. Advisors
Casdin Capital
Geode Capital Management
Squarepoint Ops
Citadel Advisors

View all funds holding Contineum Therapeutics